Sample Abstracts

All presenters must submit an abstract, which reviewers will read to rate your submission.

Please note the following requirements:

  • Abstracts should not be of a commercial or promotional nature.
  • Do not type the title of the abstract within the body of the abstract text.
  • Do not include the name of the presenter or names of other presenters in the symposium or workshop within the body of the abstract. 
  • Research abstracts must include background, methods, results, and conclusion.
  • 350-word maximum

AACME, American Psychological Association, National Association of Social Workers, and National Board of Certified Counselors review abstracts of accepted session to decide eligibility for continuing education credits.

SAMPLE: New Research Poster Abstract

Background: Recent military operations have resulted in a growing number of injured soldiers who have been evacuated for comprehensive care related to both physical and psychological trauma. Posttraumatic stress disorder (PTSD) and chronic pain have been identified as serious health problems among OEF/OIF returnees. In an effort to develop more effective treatments for veterans with comorbid chronic pain and PTSD, investigators at the VA Boston Healthcare System developed and pilot tested an intensive (3-week, 6-session) integrated chronic pain and PTSD treatment that combined elements of cognitive-processing therapy (CPT) for PTSD and cognitive-behavioral therapy (CBT) for chronic pain.

Method: A total of eight veterans with comorbid chronic pain and PTSD were recruited for participation in this pilot study. Participants were assessed by an independent evaluator at pre- and post-treatment, using multiple measures of chronic pain (i.e., West-Haven Yale Multidimensional Pain Inventory; WHYMPI), PTSD (i.e., Clinician Administered Assessment of PTSD; CAPS), and treatment satisfaction.

Results: At post-treatment there were no treatment dropouts, and participants reported a high rate of treatment satisfaction. All eight participants demonstrated significant reductions in pain-related disability and five participants no longer met criteria for PTSD.

Conclusion: The results of this pilot study support the feasibility of this treatment approach. If shown to be efficacious, the intensive treatment could be implemented before pain or PTSD become chronic, would be cost-effective and could potentially reach a greater number of veterans around the country.

SAMPLE: Workshop Abstract

Panic disorder is a debilitating anxiety disorder characterized by recurrent, unexpected panic attacks along with persistent fears of experiencing further attacks, worry about the implications of the attacks, and/or making a significant changes in behaviors associated with the attacks (i.e., agoraphobic avoidance). Making matters worse, panic disorder (PD) has historically been considered a chronic condition, in part due to the lack of availability of effective treatments.

Fortunately, research on PD has exploded over the past 20 to 25 years. As a result, a number of contributing factors thought to be involved in the etiology and maintenance of PD have been identified, and several treatments have been developed, studied, and refined.

Of the psychological treatments, cognitive-behavioral therapy (CBT) has received the greatest amount of empirical support. It has been shown to be highly efficacious, well-tolerated, and cost-effective; currently it is the only psychological treatment recommended as first-line treatments for PD. This workshop will present attendees with an overview of cognitive and behavioral theories of panic, a summary of the empirical evidence supporting CBT, and a description of how to assess and treat the disorder. Time will also be left for a question-and-answer segment for the workshop attendees.

Review more information at Guidelines for Submissions.

Contact ADAA

8701 Georgia Ave. #412
Silver Spring, MD 20910

240.485.1001

Contact ADAA

Request Publications

FacebookTwitterRSS

 

ADAA is a national nonprofit organization dedicated to the prevention, treatment, and cure of anxiety, OCD, PTSD, depression, and related disorders and to improving the lives of all people who suffer from them.